Prospective study of a tailored comprehensive cancer gene (TCCG) set built on a next generation sequencing (NGS) platform in incurable head and neck squamous cell carcinoma (The Pro-TCCG Protocol).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results